BRCA1 and ovarian carcinoma: Recent studies have suggested that approximately 15% ofall ovarian cancer patients harbour a germline mutation in BRCA1 andBRCA2, few of whom are currently being offered testing (Pal et al, 2005; Walshet al, 2011; Zhang et al,2011; Alsop et al, 2012).